Join the Atogepant group to help and get support from people like you.
Atogepant News
Atogepant Efficacious for Patients With Chronic Migraine
WEDNESDAY, June 26, 2024 – For patients with chronic migraine (CM), with and without medication overuse, atogepant is efficacious, according to a study published online June 27 in Neurology. Peter...
Migraine Prevention Med Quilipta Might Stop 'Rebound' Headaches, Too
THURSDAY, June 27, 2024 – It's a nasty cycle: Chronic migraine sufferers who use too much pain medication sometimes get smacked with rebound headaches. But new research suggests that a medication...
U.S. FDA Approves Qulipta (atogepant) for Adults With Chronic Migraine
NORTH CHICAGO, Ill., April 17, 2023 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved expanding the indication of Qulipta (atogepant) ...
FDA Approves Qulipta (atogepant) Oral CGRP Receptor Antagonist for the Preventive Treatment of Migraine
NORTH CHICAGO, Ill., Sept. 28, 2021 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Qulipta (atogepant) for the preventive treatment of...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Chronic Migraine, Migraine Prevention, Migraine Prophylaxis, Headache, Migraine